{"gene":"FABP4","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2013,"finding":"FABP4 triggers ubiquitination and subsequent proteasomal degradation of PPARγ, thereby attenuating adipogenesis. FABP4-null preadipocytes and macrophages exhibited increased PPARγ expression, and complementation of FABP4 in null macrophages reversed this increase.","method":"FABP4-null mouse preadipocytes/macrophages, complementation rescue experiments, ubiquitination assays, Western blot","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with defined molecular mechanism (PPARγ ubiquitination/degradation), complementation rescue, multiple orthogonal approaches","pmids":["24319114"],"is_preprint":false},{"year":2017,"finding":"FABP4/aP2 regulates macrophage redox signaling and NLRP3 inflammasome activation via control of UCP2 expression. Ablation of FABP4 upregulates UCP2, reduces mitochondrial protein oxidation, attenuates the mitochondrial unfolded-protein response, and ablates IL-1β secretion in response to inflammasome activation.","method":"FABP4/aP2-knockout macrophages, FABP4 inhibitor treatment, UCP2 siRNA rescue, caspase-1 cleavage assay, IL-1β secretion assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — KO with defined cellular phenotype, pharmacological inhibition, siRNA rescue, multiple orthogonal methods","pmids":["27795298"],"is_preprint":false},{"year":2017,"finding":"FABP4 is secreted via an unconventional pathway involving enclosure within endosomes and secretory lysosomes, independent of the ER-Golgi pathway, GRASP proteins, autophagy, and multivesicular bodies. Chloroquine treatment in mice inhibits this secretion.","method":"Cell fractionation, live-cell imaging, pharmacological inhibitors of secretory pathways, chloroquine treatment of mice, Western blot of plasma FABP4","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — multiple pathway inhibitors used orthogonally, in vivo validation, mechanistic pathway dissection","pmids":["29212659"],"is_preprint":false},{"year":2021,"finding":"Hormonal FABP4 forms a functional hormone complex called Fabkin with adenosine kinase (ADK) and nucleoside diphosphate kinase (NDPK), regulating extracellular ATP and ADP levels. This complex acts on pancreatic beta cells and regulates an adipose-beta-cell endocrine axis. Antibody-mediated targeting of this complex improves beta-cell function and prevents diabetes.","method":"Co-immunoprecipitation, biochemical reconstitution, extracellular nucleotide measurements, antibody neutralization in mouse models of type 1 and type 2 diabetes, beta-cell functional assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1-2 — complex identification by co-IP, functional reconstitution, in vivo antibody targeting with defined physiological readout, published in Nature with multiple orthogonal methods","pmids":["34880500"],"is_preprint":false},{"year":2023,"finding":"Endothelial cells are the major source of baseline circulating (hormonal) FABP4, contributing ~87% of basal plasma levels, whereas adipocytes are the main source of lipolysis-stimulated FABP4 increases. Endothelial FABP4 is required for lipolysis-driven insulin secretion.","method":"Cell-type-specific Fabp4 knockout mice (Adipo-KO, Endo-KO, Myeloid-KO, Total-KO), plasma FABP4 ELISA, lipolysis induction assays, insulin secretion measurements","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 — multiple conditional KO mouse lines with defined quantitative plasma measurements and functional insulin secretion readout","pmids":["37279064"],"is_preprint":false},{"year":2024,"finding":"PAK4 directly phosphorylates FABP4 at T126 and HSL at S565, impairing the FABP4-HSL interaction and thereby inhibiting lipolysis in adipose tissue. PKA-mediated degradation of PAK4 relieves this inhibition to allow lipolysis.","method":"In vitro kinase assay, site-directed mutagenesis (T126 on FABP4, S565 on HSL), co-immunoprecipitation, adipose tissue-specific PAK4 overexpression and knockout mice, lipolysis assays","journal":"Nature metabolism","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with mutagenesis identifying specific phosphorylation sites, in vivo genetic models, co-IP demonstrating functional consequence on FABP4-HSL interaction","pmids":["38216738"],"is_preprint":false},{"year":2019,"finding":"Exogenous FABP4 interferes with adipocyte differentiation and induces p38/HSL-mediated lipolysis and p38/NF-κB-mediated inflammation in adipocytes in vitro and in vivo. These effects are reversed by FABP4 inhibitor I-9 or p38 MAPK inhibitor SB203580.","method":"3T3-L1 preadipocyte/adipocyte treatment with recombinant FABP4, p38 MAPK inhibitor, FABP4 inhibitor, in vivo mouse injections, Western blot for p38/HSL/NF-κB phosphorylation, RT-qPCR","journal":"Endocrine","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological rescue experiments in vitro and in vivo, but single-lab study","pmids":["31845180"],"is_preprint":false},{"year":2016,"finding":"FABP4 overexpression in cardiomyocytes activates ERK phosphorylation and aggravates pressure overload-induced cardiac hypertrophy; this is inhibited by ERK inhibitor PD098059 or FABP4 inhibitor BMS309403.","method":"Heart-specific FABP4 transgenic mice (α-MHC promoter), transverse aortic constriction (TAC), Western blot for p-ERK, hypertrophic marker gene expression, pharmacological inhibition","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — transgenic mouse model with TAC and pharmacological rescue, defined signaling pathway, single lab","pmids":["27294862"],"is_preprint":false},{"year":2021,"finding":"FABP4 in tumor-associated macrophages directly binds ATPB and accelerates its ubiquitination, decreasing intracellular ATP levels, which deactivates the NF-κB/RelA-IL1α pathway and reprograms macrophages to an anti-inflammatory phenotype promoting neuroblastoma progression.","method":"Co-immunoprecipitation (FABP4-ATPB interaction), ubiquitination assays, NF-κB pathway analysis, IL1α blocking antibody rescue, in vitro and in vivo tumor growth assays","journal":"Clinical and translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP identifying direct binding partner, ubiquitination assay, pathway rescue with blocking antibody; single lab","pmids":["33931964"],"is_preprint":false},{"year":2018,"finding":"Macrophage FABP4 is required for CXCL1 production, neutrophil recruitment, and bacterial clearance in Pseudomonas aeruginosa pneumonia. Bone marrow chimera experiments confirmed macrophages as the protective source of FABP4; recombinant CXCL1 rescued the FABP4-/- susceptibility phenotype.","method":"FABP4-/- mice, bone marrow chimeras, intratracheal P. aeruginosa infection, CXCL1 ELISA, recombinant CXCL1 rescue experiment","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — bone marrow chimeras establishing cell-type specificity, cytokine rescue experiment, mechanistic pathway defined; multiple orthogonal approaches","pmids":["30462529"],"is_preprint":false},{"year":2018,"finding":"FABP4 deficiency in eosinophils impairs cell spreading, adhesion to ICAM-1 (via reduced β2-integrin expression), migration, F-actin polymerization, calcium flux, and ERK(1/2) phosphorylation in response to eotaxin-1, reducing eosinophil recruitment and allergic airway inflammation in vivo.","method":"FABP4-/- eosinophils, in vitro adhesion/migration assays, F-actin polymerization assay, calcium flux measurement, ERK phosphorylation (Western blot), cockroach antigen mouse model","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"High","confidence_rationale":"Tier 2 — KO cells with multiple orthogonal functional readouts in vitro and in vivo model; multiple mechanisms defined","pmids":["29696987"],"is_preprint":false},{"year":2021,"finding":"FABP4 activates the JAK2/STAT2 inflammatory pathway in macrophages via Rap1a-induced Tyr416 phosphorylation and membrane translocation of c-Src; SOCS1 provides a negative feedback loop inhibiting JAK2/STAT2 and Rap1a expression.","method":"Macrophage cell culture with Hcy stimulation, Western blot for JAK2/STAT2/c-Src phosphorylation, Rap1a knockdown/overexpression, ApoE-/- mouse atherosclerosis model","journal":"Laboratory investigation","confidence":"Medium","confidence_rationale":"Tier 2 — defined signaling pathway with genetic manipulation (Rap1a knockdown), in vivo model; single lab","pmids":["34725437"],"is_preprint":false},{"year":2018,"finding":"Extracellular FABP4 is taken up by endothelial cells via cytokeratin 1 (CK1) acting as a membrane receptor; direct FABP4-CK1 binding was confirmed by surface plasmon resonance, and CK1 knockdown blocked eFABP4-mediated pro-inflammatory and pro-oxidative (NF-κB, NRF2) effects in endothelial cells.","method":"Surface plasmon resonance (direct protein-protein binding), siRNA knockdown of CK1 in HUVECs, Western blot for NF-κB/NRF2 nuclear translocation, cellular uptake assays","journal":"Biochimica et biophysica acta. Molecular and cell biology of lipids","confidence":"Medium","confidence_rationale":"Tier 1-2 — SPR for direct binding confirmation, siRNA knockdown with defined functional consequence; single lab","pmids":["30521939"],"is_preprint":false},{"year":2023,"finding":"FABP4 in liver sinusoidal endothelial cells (LSECs) promotes CXCL10 expression via NF-κB/p65 signaling, which recruits CXCR3+ macrophages and drives M1 macrophage polarization during NAFLD progression. FABP4 inhibition suppresses this pathway.","method":"HFD mouse model, FABP4 inhibitor treatment, flow cytometry for macrophage subtypes, NF-κB inhibitor experiments, recombinant CXCL10 and CXCR3 inhibitor rescue, Western blot for nuclear p65","journal":"Biochimica et biophysica acta. Molecular basis of disease","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic pathway defined with pharmacological and cytokine rescue experiments in vitro and in vivo; single lab","pmids":["37487374"],"is_preprint":false},{"year":2013,"finding":"Tamoxifen inhibits macrophage FABP4 expression through combined effects on the glucocorticoid receptor (GR) activating a negative GRE (nGRE) and inhibiting the PPARγ regulatory element (PPRE) in the Fabp4 promoter, reducing foam cell formation and atherosclerosis.","method":"Promoter-reporter assays, EMSA, ChIP, siRNA knockdown of FABP4, primary macrophages from wild-type/ApoE-/- mice, in vivo tamoxifen administration","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 — EMSA and ChIP identifying specific cis-regulatory elements, promoter-reporter assays, in vivo validation; multiple orthogonal methods","pmids":["23805908"],"is_preprint":false},{"year":2014,"finding":"Bisphenol A increases FABP4/aP2 expression in 3T3-L1 cells through enhanced transcriptional activity of C/EBPδ and glucocorticoid receptor (GR) at the FABP4 promoter, independently of PPARγ or C/EBPα elevation.","method":"3T3-L1 differentiation assay, RT-qPCR, Western blot, promoter-reporter assay, nuclear receptor pathway analysis","journal":"Adipocyte","confidence":"Medium","confidence_rationale":"Tier 3 — promoter activity assay with pharmacological dissection; single lab, limited mechanistic depth","pmids":["25068083"],"is_preprint":false},{"year":2022,"finding":"FABP4 secreted by M1-polarized macrophages promotes synovitis and angiogenesis in rheumatoid arthritis. mTORC1 (regulated by TSC1 and Rheb1 in myeloid cells) controls FABP4 expression in macrophages; inhibiting FABP4 with BMS309403 or reducing its expression via mTORC1 inhibition alleviates RA.","method":"Myeloid-specific TSC1-KO and Rheb1-KO mice, BMS309403 pharmacological inhibition, in vitro synoviocyte/angiogenesis assays, in vivo mouse RA models","journal":"Bone research","confidence":"Medium","confidence_rationale":"Tier 2 — cell-type-specific genetic models placing FABP4 downstream of mTORC1 signaling; single lab","pmids":["35729106"],"is_preprint":false},{"year":2023,"finding":"FABP4 exerts a negative feedback loop on FAT/CD36 signaling in adipocytes: fatty acid-mediated FAT/CD36-PPARγ transcriptional activation induces FABP4 accumulation, which in turn reduces FAT/CD36 activity and controls adipocyte size and number (fat mass expandability).","method":"Human adipose stem cells, 3T3-L1 and 3T3-MBX cell lines, real-time proliferation/differentiation/lipolysis/lipid uptake assays, FABP4 overexpression/knockdown, FAT/CD36 signaling pathway analysis","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — defined feedback loop with gain/loss-of-function approaches; single lab","pmids":["36674544"],"is_preprint":false},{"year":2021,"finding":"PXR transcriptionally upregulates FABP4 expression in HepG2 cells in response to valproate, and FABP4 promotes lipid/triglyceride accumulation; knockdown of PXR reduces FABP4 induction and lipid accumulation, while FABP4 overexpression enhances VPA-induced steatosis.","method":"PXR siRNA knockdown, PXR overexpression, FABP4 overexpression in HepG2 cells, triglyceride measurement, lipid staining","journal":"Toxicology letters","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal gain/loss-of-function for both PXR and FABP4; single lab","pmids":["33901630"],"is_preprint":false}],"current_model":"FABP4 is an intracellular lipid chaperone and secreted adipokine/hormone that: (1) regulates adipogenesis and PPARγ levels by promoting PPARγ ubiquitination and proteasomal degradation; (2) is secreted unconventionally via endosomes and secretory lysosomes (primarily from endothelial cells at baseline and from adipocytes during lipolysis); (3) forms a hormone complex (Fabkin) with ADK and NDPK to regulate extracellular nucleotide levels and beta-cell function; (4) is directly phosphorylated by PAK4 at T126, impairing its interaction with HSL to inhibit lipolysis; (5) controls macrophage redox signaling and NLRP3 inflammasome activation via UCP2; and (6) is taken up by endothelial cells via cytokeratin 1 to activate inflammatory signaling."},"narrative":{"teleology":[{"year":2013,"claim":"Establishing how FABP4 controls adipogenesis at the molecular level: FABP4 was shown to promote PPARγ ubiquitination and proteasomal degradation, explaining how a fatty acid-binding protein feeds back to limit the master adipogenic transcription factor.","evidence":"FABP4-null preadipocytes/macrophages with elevated PPARγ, complementation rescue, ubiquitination assays","pmids":["24319114"],"confidence":"High","gaps":["E3 ubiquitin ligase mediating FABP4-dependent PPARγ ubiquitination not identified","structural basis for FABP4-PPARγ interaction unknown"]},{"year":2013,"claim":"Defining transcriptional regulation of FABP4 itself: the FABP4 promoter was shown to integrate signals from both GR (via a negative GRE) and PPARγ (via PPRE), explaining how tamoxifen suppresses macrophage FABP4 and reduces foam cell formation.","evidence":"EMSA, ChIP, promoter-reporter assays, in vivo tamoxifen treatment in ApoE−/− mice","pmids":["23805908"],"confidence":"High","gaps":["Whether other nuclear receptors contribute to FABP4 regulation in non-macrophage lineages not tested"]},{"year":2017,"claim":"Revealing how FABP4 links lipid sensing to innate immune activation: FABP4 was found to control the NLRP3 inflammasome via UCP2-dependent mitochondrial redox regulation in macrophages, connecting lipid metabolism to IL-1β production.","evidence":"FABP4 KO and inhibitor-treated macrophages, UCP2 siRNA rescue, caspase-1 cleavage and IL-1β secretion assays","pmids":["27795298"],"confidence":"High","gaps":["Mechanism by which FABP4 regulates UCP2 expression (transcriptional vs. post-transcriptional) not resolved","whether specific lipid cargo of FABP4 is required for inflammasome regulation unknown"]},{"year":2017,"claim":"Identifying the unconventional secretory route of FABP4: secretion occurs via endosomes and secretory lysosomes, independent of ER-Golgi, GRASP proteins, autophagy, or multivesicular bodies, explaining how a cytosolic protein reaches the circulation.","evidence":"Cell fractionation, live-cell imaging, pharmacological pathway inhibitors, in vivo chloroquine treatment reducing plasma FABP4","pmids":["29212659"],"confidence":"High","gaps":["Signal or motif on FABP4 that targets it to endosomes not identified","regulation of secretory lysosome exocytosis of FABP4 not defined"]},{"year":2018,"claim":"Establishing cell-autonomous roles in immune cell function beyond macrophages: FABP4 deficiency in eosinophils impaired integrin-mediated adhesion, F-actin polymerization, calcium flux, and migration, revealing a general role in leukocyte cytoskeletal dynamics.","evidence":"FABP4-KO eosinophils, adhesion/migration assays, calcium flux, ERK phosphorylation, allergic airway inflammation model","pmids":["29696987"],"confidence":"High","gaps":["Direct molecular target linking FABP4 to β2-integrin surface expression not identified","whether lipid-binding pocket occupancy is required for cytoskeletal effects unknown"]},{"year":2018,"claim":"Identifying a membrane receptor for extracellular FABP4: cytokeratin 1 (CK1) on endothelial cells was shown by surface plasmon resonance to directly bind FABP4, and CK1 knockdown blocked FABP4-mediated NF-κB and NRF2 activation, establishing a receptor-mediated uptake mechanism.","evidence":"SPR direct binding, CK1 siRNA in HUVECs, NF-κB/NRF2 nuclear translocation assays","pmids":["30521939"],"confidence":"Medium","gaps":["CK1 as a FABP4 receptor not independently replicated","whether CK1 mediates FABP4 signaling in non-endothelial cells untested","downstream signaling cascade between CK1 engagement and NF-κB activation not mapped"]},{"year":2018,"claim":"Demonstrating a macrophage-specific protective role in innate immunity: FABP4 in macrophages was required for CXCL1 production and neutrophil recruitment during bacterial pneumonia, with bone marrow chimeras establishing macrophages as the protective cell source.","evidence":"FABP4−/− mice, bone marrow chimeras, Pseudomonas aeruginosa pneumonia model, recombinant CXCL1 rescue","pmids":["30462529"],"confidence":"High","gaps":["Molecular mechanism connecting FABP4 to CXCL1 transcription in macrophages not defined"]},{"year":2021,"claim":"Discovering the Fabkin hormone complex: FABP4 was found to form a functional extracellular complex with ADK and NDPK that regulates ATP/ADP levels and acts on pancreatic β-cells, transforming understanding of FABP4 from intracellular chaperone to systemic hormone.","evidence":"Co-immunoprecipitation, biochemical reconstitution, extracellular nucleotide measurements, anti-Fabkin antibody in mouse diabetes models","pmids":["34880500"],"confidence":"High","gaps":["Stoichiometry and structural basis of the Fabkin complex not resolved","how FABP4 and its partners are co-secreted or assemble extracellularly not determined"]},{"year":2023,"claim":"Resolving the cellular source of circulating FABP4: conditional KO mice revealed endothelial cells as the dominant source of basal circulating FABP4 (~87%) while adipocytes contribute the lipolysis-stimulated increase, establishing tissue-specific endocrine roles.","evidence":"Cell-type-specific Fabp4 KO mice (adipocyte, endothelial, myeloid, total), plasma ELISA, lipolysis-stimulated insulin secretion assays","pmids":["37279064"],"confidence":"High","gaps":["Whether endothelial and adipocyte FABP4 differ in Fabkin complex formation not tested","signals regulating basal endothelial FABP4 secretion not identified"]},{"year":2024,"claim":"Identifying a direct kinase controlling FABP4-HSL interaction: PAK4 phosphorylates FABP4 at T126 and HSL at S565, disrupting their interaction and inhibiting lipolysis; PKA-mediated PAK4 degradation relieves this brake, integrating FABP4 into the catecholamine-lipolysis signaling cascade.","evidence":"In vitro kinase assay, T126/S565 mutagenesis, co-IP, adipose-specific PAK4 overexpression/KO mice, lipolysis assays","pmids":["38216738"],"confidence":"High","gaps":["Whether T126 phosphorylation also affects FABP4 secretion or Fabkin complex formation not examined","crystal structure of phospho-T126 FABP4 not available"]},{"year":null,"claim":"Key unresolved questions include: how the Fabkin complex assembles and signals at target cells, what lipid cargoes are required for distinct FABP4 functions, and how FABP4 is sorted into secretory lysosomes for unconventional secretion.","evidence":"","pmids":[],"confidence":"Low","gaps":["Structural basis and stoichiometry of Fabkin complex","lipid-cargo dependence of individual FABP4 functions","sorting signal for FABP4 entry into secretory lysosomes","whether CK1-mediated uptake applies to cell types beyond endothelium"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,5,17]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,3,17]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[3,4]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1,5]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[2,3,4,12]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[2]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,5,17,18]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,9,10]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,5,7,11]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,8]}],"complexes":["Fabkin (FABP4-ADK-NDPK)"],"partners":["HSL","PAK4","ADK","NDPK","PPARΓ","CK1 (KRT1)","ATPB (ATP5B)","UCP2"],"other_free_text":[]},"mechanistic_narrative":"FABP4 is an intracellular lipid chaperone and unconventionally secreted adipokine that integrates lipid metabolism, inflammatory signaling, and systemic endocrine communication across adipocytes, macrophages, and endothelial cells. Intracellularly, FABP4 promotes PPARγ ubiquitination and proteasomal degradation to restrain adipogenesis [PMID:24319114], participates in a negative feedback loop with FAT/CD36 to control fat mass expandability [PMID:36674544], and its interaction with hormone-sensitive lipase (HSL) is regulated by PAK4-mediated phosphorylation at T126 to control lipolysis [PMID:38216738]. Secreted FABP4 forms the Fabkin hormone complex with adenosine kinase and nucleoside diphosphate kinase to regulate extracellular ATP/ADP levels and pancreatic β-cell insulin secretion, with endothelial cells contributing ~87% of basal circulating FABP4 via an unconventional endosome/secretory lysosome pathway [PMID:34880500, PMID:37279064, PMID:29212659]. In macrophages, FABP4 controls NLRP3 inflammasome activation through UCP2-dependent mitochondrial redox regulation [PMID:27795298], drives CXCL1-dependent neutrophil recruitment during bacterial infection [PMID:30462529], and in eosinophils supports integrin-mediated adhesion, migration, and cytoskeletal dynamics [PMID:29696987]."},"prefetch_data":{"uniprot":{"accession":"P15090","full_name":"Fatty acid-binding protein, adipocyte","aliases":["Adipocyte lipid-binding protein","ALBP","Adipocyte-type fatty acid-binding protein","A-FABP","AFABP","Fatty acid-binding protein 4"],"length_aa":132,"mass_kda":14.7,"function":"Lipid transport protein in adipocytes. Binds both long chain fatty acids and retinoic acid. Delivers long-chain fatty acids and retinoic acid to their cognate receptors in the nucleus","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/P15090/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FABP4","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FABP4","total_profiled":1310},"omim":[{"mim_id":"620847","title":"BONE MORPHOGENETIC PROTEIN 8A; BMP8A","url":"https://www.omim.org/entry/620847"},{"mim_id":"619246","title":"SPEXIN HORMONE; SPX","url":"https://www.omim.org/entry/619246"},{"mim_id":"618923","title":"FATTY ACID-BINDING PROTEIN 12; FABP12","url":"https://www.omim.org/entry/618923"},{"mim_id":"612991","title":"ASXL TRANSCRIPTIONAL REGULATOR 2; ASXL2","url":"https://www.omim.org/entry/612991"},{"mim_id":"612990","title":"ASXL TRANSCRIPTIONAL REGULATOR 1; ASXL1","url":"https://www.omim.org/entry/612990"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":3555.6},{"tissue":"breast","ntpm":2416.5}],"url":"https://www.proteinatlas.org/search/FABP4"},"hgnc":{"alias_symbol":["A-FABP","aP2"],"prev_symbol":[]},"alphafold":{"accession":"P15090","domains":[{"cath_id":"2.40.128.20","chopping":"2-130","consensus_level":"high","plddt":96.0888,"start":2,"end":130}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P15090","model_url":"https://alphafold.ebi.ac.uk/files/AF-P15090-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P15090-F1-predicted_aligned_error_v6.png","plddt_mean":95.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FABP4","jax_strain_url":"https://www.jax.org/strain/search?query=FABP4"},"sequence":{"accession":"P15090","fasta_url":"https://rest.uniprot.org/uniprotkb/P15090.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P15090/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P15090"}},"corpus_meta":[{"pmid":"32522044","id":"PMC_32522044","title":"Advances in AP2/ERF super-family transcription factors in plant.","date":"2020","source":"Critical reviews in biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/32522044","citation_count":398,"is_preprint":false},{"pmid":"15231271","id":"PMC_15231271","title":"Regulation of disease resistance pathways by AP2/ERF transcription factors.","date":"2004","source":"Current opinion in plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/15231271","citation_count":366,"is_preprint":false},{"pmid":"24319114","id":"PMC_24319114","title":"FABP4 attenuates PPARγ and adipogenesis and is inversely correlated with PPARγ in adipose tissues.","date":"2013","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/24319114","citation_count":269,"is_preprint":false},{"pmid":"32054768","id":"PMC_32054768","title":"Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/32054768","citation_count":226,"is_preprint":false},{"pmid":"34030117","id":"PMC_34030117","title":"Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence.","date":"2021","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/34030117","citation_count":226,"is_preprint":false},{"pmid":"21171999","id":"PMC_21171999","title":"Genomic and transcriptomic analysis of the AP2/ERF superfamily in Vitis vinifera.","date":"2010","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/21171999","citation_count":201,"is_preprint":false},{"pmid":"18541913","id":"PMC_18541913","title":"Specific DNA-binding by apicomplexan AP2 transcription factors.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18541913","citation_count":191,"is_preprint":false},{"pmid":"25061211","id":"PMC_25061211","title":"Clathrin adaptors. AP2 controls clathrin polymerization with a membrane-activated switch.","date":"2014","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/25061211","citation_count":187,"is_preprint":false},{"pmid":"30705117","id":"PMC_30705117","title":"Adipokine FABP4 integrates energy stores and counterregulatory metabolic responses.","date":"2019","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/30705117","citation_count":156,"is_preprint":false},{"pmid":"21126543","id":"PMC_21126543","title":"The Apicomplexan AP2 family: integral factors regulating Plasmodium development.","date":"2010","source":"Molecular and biochemical parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/21126543","citation_count":155,"is_preprint":false},{"pmid":"24603492","id":"PMC_24603492","title":"TBC1D5 and the AP2 complex regulate ATG9 trafficking and initiation of autophagy.","date":"2014","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/24603492","citation_count":146,"is_preprint":false},{"pmid":"11412854","id":"PMC_11412854","title":"Role of AP2/EREBP transcription factors in gene regulation during abiotic stress.","date":"2001","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11412854","citation_count":143,"is_preprint":false},{"pmid":"16388920","id":"PMC_16388920","title":"Molecular evolution of the AP2 subfamily.","date":"2006","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16388920","citation_count":128,"is_preprint":false},{"pmid":"15708341","id":"PMC_15708341","title":"Homing into the origin of the AP2 DNA binding domain.","date":"2005","source":"Trends in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/15708341","citation_count":97,"is_preprint":false},{"pmid":"35729106","id":"PMC_35729106","title":"FABP4 secreted by M1-polarized macrophages promotes synovitis and angiogenesis to exacerbate rheumatoid arthritis.","date":"2022","source":"Bone research","url":"https://pubmed.ncbi.nlm.nih.gov/35729106","citation_count":92,"is_preprint":false},{"pmid":"33088219","id":"PMC_33088219","title":"FABP4 promotes invasion and metastasis of colon cancer by regulating fatty acid transport.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/33088219","citation_count":89,"is_preprint":false},{"pmid":"32743075","id":"PMC_32743075","title":"Architecture of the AP2/clathrin coat on the membranes of clathrin-coated vesicles.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32743075","citation_count":88,"is_preprint":false},{"pmid":"11226182","id":"PMC_11226182","title":"Petunia Ap2-like genes and their role in flower and seed development.","date":"2001","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/11226182","citation_count":82,"is_preprint":false},{"pmid":"28738306","id":"PMC_28738306","title":"Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review.","date":"2017","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28738306","citation_count":80,"is_preprint":false},{"pmid":"27795298","id":"PMC_27795298","title":"FABP4/aP2 Regulates Macrophage Redox Signaling and Inflammasome Activation via Control of UCP2.","date":"2017","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27795298","citation_count":78,"is_preprint":false},{"pmid":"29212659","id":"PMC_29212659","title":"Unconventional secretion of FABP4 by endosomes and secretory lysosomes.","date":"2017","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/29212659","citation_count":78,"is_preprint":false},{"pmid":"34880500","id":"PMC_34880500","title":"A hormone complex of FABP4 and nucleoside kinases regulates islet function.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34880500","citation_count":77,"is_preprint":false},{"pmid":"15110783","id":"PMC_15110783","title":"Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15110783","citation_count":68,"is_preprint":false},{"pmid":"23139800","id":"PMC_23139800","title":"FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23139800","citation_count":68,"is_preprint":false},{"pmid":"28143399","id":"PMC_28143399","title":"Expansion and stress responses of the AP2/EREBP superfamily in cotton.","date":"2017","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/28143399","citation_count":67,"is_preprint":false},{"pmid":"27568980","id":"PMC_27568980","title":"Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.","date":"2016","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/27568980","citation_count":64,"is_preprint":false},{"pmid":"32054756","id":"PMC_32054756","title":"Transcription factor AP2 controls cnidarian germ cell induction.","date":"2020","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/32054756","citation_count":55,"is_preprint":false},{"pmid":"36233316","id":"PMC_36233316","title":"Molecular Events of Rice AP2/ERF Transcription Factors.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36233316","citation_count":55,"is_preprint":false},{"pmid":"31651326","id":"PMC_31651326","title":"High expression of FABP4 and FABP6 in patients with colorectal cancer.","date":"2019","source":"World journal of surgical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31651326","citation_count":55,"is_preprint":false},{"pmid":"39196924","id":"PMC_39196924","title":"An AP2/ERF transcription factor confers chilling tolerance in rice.","date":"2024","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/39196924","citation_count":54,"is_preprint":false},{"pmid":"35851621","id":"PMC_35851621","title":"Improving bread wheat yield through modulating an unselected AP2/ERF gene.","date":"2022","source":"Nature plants","url":"https://pubmed.ncbi.nlm.nih.gov/35851621","citation_count":54,"is_preprint":false},{"pmid":"31727678","id":"PMC_31727678","title":"Mutually Regulated AP2/ERF Gene Clusters Modulate Biosynthesis of Specialized Metabolites in Plants.","date":"2019","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31727678","citation_count":53,"is_preprint":false},{"pmid":"14986134","id":"PMC_14986134","title":"Analysis of gymnosperm two-AP2-domain-containing genes.","date":"2004","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/14986134","citation_count":52,"is_preprint":false},{"pmid":"31845180","id":"PMC_31845180","title":"Exogenous FABP4 interferes with differentiation, promotes lipolysis and inflammation in adipocytes.","date":"2019","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/31845180","citation_count":52,"is_preprint":false},{"pmid":"31097687","id":"PMC_31097687","title":"FABP4 contributes to renal interstitial fibrosis via mediating inflammation and lipid metabolism.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31097687","citation_count":48,"is_preprint":false},{"pmid":"35899119","id":"PMC_35899119","title":"Therapeutic Implications of FABP4 in Cancer: An Emerging Target to Tackle Cancer.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/35899119","citation_count":47,"is_preprint":false},{"pmid":"26869021","id":"PMC_26869021","title":"Expansion and stress responses of AP2/EREBP superfamily in Brachypodium distachyon.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26869021","citation_count":47,"is_preprint":false},{"pmid":"30999003","id":"PMC_30999003","title":"Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.","date":"2019","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/30999003","citation_count":47,"is_preprint":false},{"pmid":"31353312","id":"PMC_31353312","title":"AAGAB Controls AP2 Adaptor Assembly in Clathrin-Mediated Endocytosis.","date":"2019","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/31353312","citation_count":45,"is_preprint":false},{"pmid":"25068083","id":"PMC_25068083","title":"Bisphenol A increases aP2 expression in 3T3L1 by enhancing the transcriptional activity of nuclear receptors at the promoter.","date":"2014","source":"Adipocyte","url":"https://pubmed.ncbi.nlm.nih.gov/25068083","citation_count":45,"is_preprint":false},{"pmid":"32323475","id":"PMC_32323475","title":"AP-2 reduces amyloidogenesis by promoting BACE1 trafficking and degradation in neurons.","date":"2020","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/32323475","citation_count":44,"is_preprint":false},{"pmid":"31313456","id":"PMC_31313456","title":"Conformational regulation of AP1 and AP2 clathrin adaptor complexes.","date":"2019","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/31313456","citation_count":43,"is_preprint":false},{"pmid":"35849941","id":"PMC_35849941","title":"Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022.","date":"2022","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35849941","citation_count":41,"is_preprint":false},{"pmid":"25310985","id":"PMC_25310985","title":"Scribble1/AP2 complex coordinates NMDA receptor endocytic recycling.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25310985","citation_count":41,"is_preprint":false},{"pmid":"33615754","id":"PMC_33615754","title":"High expression of FABP4 in colorectal cancer and its clinical significance.","date":"2021","source":"Journal of Zhejiang University. Science. B","url":"https://pubmed.ncbi.nlm.nih.gov/33615754","citation_count":40,"is_preprint":false},{"pmid":"19390821","id":"PMC_19390821","title":"An ARIA-interacting AP2 domain protein is a novel component of ABA signaling.","date":"2009","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/19390821","citation_count":40,"is_preprint":false},{"pmid":"29558898","id":"PMC_29558898","title":"The mining and evolutionary investigation of AP2/ERF genes in pear (Pyrus).","date":"2018","source":"BMC plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/29558898","citation_count":40,"is_preprint":false},{"pmid":"33931964","id":"PMC_33931964","title":"FABP4 deactivates NF-κB-IL1α pathway by ubiquitinating ATPB in tumor-associated macrophages and promotes neuroblastoma progression.","date":"2021","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33931964","citation_count":38,"is_preprint":false},{"pmid":"36842611","id":"PMC_36842611","title":"Targeting FABP4 in elderly mice rejuvenates liver metabolism and ameliorates aging-associated metabolic disorders.","date":"2023","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/36842611","citation_count":37,"is_preprint":false},{"pmid":"34725437","id":"PMC_34725437","title":"FABP4 activates the JAK2/STAT2 pathway via Rap1a in the homocysteine-induced macrophage inflammatory response in ApoE-/- mice atherosclerosis.","date":"2021","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/34725437","citation_count":37,"is_preprint":false},{"pmid":"27570529","id":"PMC_27570529","title":"Origination, Expansion, Evolutionary Trajectory, and Expression Bias of AP2/ERF Superfamily in Brassica napus.","date":"2016","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/27570529","citation_count":37,"is_preprint":false},{"pmid":"34502295","id":"PMC_34502295","title":"A-FABP in Metabolic Diseases and the Therapeutic Implications: An Update.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34502295","citation_count":36,"is_preprint":false},{"pmid":"28385723","id":"PMC_28385723","title":"Fabp4-Cre-mediated Sirt6 deletion impairs adipose tissue function and metabolic homeostasis in mice.","date":"2017","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28385723","citation_count":36,"is_preprint":false},{"pmid":"30462529","id":"PMC_30462529","title":"Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia.","date":"2018","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/30462529","citation_count":35,"is_preprint":false},{"pmid":"29696987","id":"PMC_29696987","title":"FABP4 regulates eosinophil recruitment and activation in allergic airway inflammation.","date":"2018","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29696987","citation_count":34,"is_preprint":false},{"pmid":"27294862","id":"PMC_27294862","title":"Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27294862","citation_count":34,"is_preprint":false},{"pmid":"25280936","id":"PMC_25280936","title":"fabp4 is central to eight obesity associated genes: a functional gene network-based polymorphic study.","date":"2014","source":"Journal of theoretical biology","url":"https://pubmed.ncbi.nlm.nih.gov/25280936","citation_count":33,"is_preprint":false},{"pmid":"36674544","id":"PMC_36674544","title":"FABP4 Controls Fat Mass Expandability (Adipocyte Size and Number) through Inhibition of CD36/SR-B2 Signalling.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36674544","citation_count":32,"is_preprint":false},{"pmid":"27936164","id":"PMC_27936164","title":"Transcriptome and Metabolome Analyses in Exogenous FABP4- and FABP5-Treated Adipose-Derived Stem Cells.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27936164","citation_count":29,"is_preprint":false},{"pmid":"37487374","id":"PMC_37487374","title":"FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression.","date":"2023","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/37487374","citation_count":28,"is_preprint":false},{"pmid":"38377465","id":"PMC_38377465","title":"Oleic acid-PPARγ-FABP4 loop fuels cholangiocarcinoma colonization in lymph node metastases microenvironment.","date":"2024","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/38377465","citation_count":28,"is_preprint":false},{"pmid":"34119684","id":"PMC_34119684","title":"Mechanisms of triggering malaria gametocytogenesis by AP2-G.","date":"2021","source":"Parasitology international","url":"https://pubmed.ncbi.nlm.nih.gov/34119684","citation_count":28,"is_preprint":false},{"pmid":"24390652","id":"PMC_24390652","title":"Circulating FABP4 is a marker of metabolic and cardiovascular risk in SLE patients.","date":"2014","source":"Lupus","url":"https://pubmed.ncbi.nlm.nih.gov/24390652","citation_count":27,"is_preprint":false},{"pmid":"30306857","id":"PMC_30306857","title":"Role of Fatty Acid Binding Protein 4 (FABP4) in Kidney Disease.","date":"2020","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30306857","citation_count":26,"is_preprint":false},{"pmid":"26687459","id":"PMC_26687459","title":"Expression of FABP4, adipsin and adiponectin in Paneth cells is modulated by gut Lactobacillus.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26687459","citation_count":26,"is_preprint":false},{"pmid":"25908855","id":"PMC_25908855","title":"ENTH and ANTH domain proteins participate in AP2-independent clathrin-mediated endocytosis.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25908855","citation_count":26,"is_preprint":false},{"pmid":"37905351","id":"PMC_37905351","title":"Oridonin attenuates atherosclerosis by inhibiting foam macrophage formation and inflammation through FABP4/PPARγ signalling.","date":"2023","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37905351","citation_count":26,"is_preprint":false},{"pmid":"38216738","id":"PMC_38216738","title":"p21-activated kinase 4 counteracts PKA-dependent lipolysis by phosphorylating FABP4 and HSL.","date":"2024","source":"Nature metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/38216738","citation_count":25,"is_preprint":false},{"pmid":"27236410","id":"PMC_27236410","title":"Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia.","date":"2016","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/27236410","citation_count":24,"is_preprint":false},{"pmid":"32605158","id":"PMC_32605158","title":"An AP2/ERF Gene, HuERF1, from Pitaya (Hylocereus undatus) Positively Regulates Salt Tolerance.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32605158","citation_count":23,"is_preprint":false},{"pmid":"38698167","id":"PMC_38698167","title":"The Effects of FABP4 on Cardiovascular Disease in the Aging Population.","date":"2024","source":"Current atherosclerosis reports","url":"https://pubmed.ncbi.nlm.nih.gov/38698167","citation_count":22,"is_preprint":false},{"pmid":"33071982","id":"PMC_33071982","title":"Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus.","date":"2020","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/33071982","citation_count":22,"is_preprint":false},{"pmid":"24616412","id":"PMC_24616412","title":"Transcription factor AP2 epsilon (Tfap2e) regulates neural crest specification in Xenopus.","date":"2014","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24616412","citation_count":22,"is_preprint":false},{"pmid":"30015163","id":"PMC_30015163","title":"Variation in the FABP4 gene affects carcass and growth traits in sheep.","date":"2018","source":"Meat science","url":"https://pubmed.ncbi.nlm.nih.gov/30015163","citation_count":21,"is_preprint":false},{"pmid":"37279064","id":"PMC_37279064","title":"Endothelial-derived FABP4 constitutes the majority of basal circulating hormone and regulates lipolysis-driven insulin secretion.","date":"2023","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/37279064","citation_count":21,"is_preprint":false},{"pmid":"29850615","id":"PMC_29850615","title":"Intermittent High Glucose Exacerbates A-FABP Activation and Inflammatory Response through TLR4-JNK Signaling in THP-1 Cells.","date":"2018","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/29850615","citation_count":21,"is_preprint":false},{"pmid":"37354697","id":"PMC_37354697","title":"Identification of Andrographolide as a novel FABP4 inhibitor for osteoarthritis treatment.","date":"2023","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37354697","citation_count":20,"is_preprint":false},{"pmid":"19844814","id":"PMC_19844814","title":"FABP4: a novel candidate gene for polycystic ovary syndrome.","date":"2009","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/19844814","citation_count":20,"is_preprint":false},{"pmid":"28916654","id":"PMC_28916654","title":"Biallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/28916654","citation_count":20,"is_preprint":false},{"pmid":"15890474","id":"PMC_15890474","title":"Sp1 and AP2 enhance promoter activity of the mouse GM3-synthase gene.","date":"2005","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/15890474","citation_count":20,"is_preprint":false},{"pmid":"23805908","id":"PMC_23805908","title":"Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPARγ pathways.","date":"2013","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/23805908","citation_count":20,"is_preprint":false},{"pmid":"37969743","id":"PMC_37969743","title":"Targeting Kindlin-2 in adipocytes increases bone mass through inhibiting FAS/PPARγ/FABP4 signaling in mice.","date":"2023","source":"Acta pharmaceutica Sinica. B","url":"https://pubmed.ncbi.nlm.nih.gov/37969743","citation_count":18,"is_preprint":false},{"pmid":"35457171","id":"PMC_35457171","title":"Microglial FABP4-UCP2 Axis Modulates Neuroinflammation and Cognitive Decline in Obese Mice.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35457171","citation_count":18,"is_preprint":false},{"pmid":"27856250","id":"PMC_27856250","title":"Ectopical expression of FABP4 gene can induce bovine muscle-derived stem cells adipogenesis.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27856250","citation_count":18,"is_preprint":false},{"pmid":"31464684","id":"PMC_31464684","title":"A structural mechanism for phosphorylation-dependent inactivation of the AP2 complex.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31464684","citation_count":18,"is_preprint":false},{"pmid":"36690278","id":"PMC_36690278","title":"AaWIN1, an AP2/ERF protein, positively regulates glandular secretory trichome initiation in Artemisia annua.","date":"2023","source":"Plant science : an international journal of experimental plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/36690278","citation_count":18,"is_preprint":false},{"pmid":"30818771","id":"PMC_30818771","title":"FABP4 in Gestational Diabetes-Association between Mothers and Offspring.","date":"2019","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30818771","citation_count":18,"is_preprint":false},{"pmid":"24450359","id":"PMC_24450359","title":"Adaptor protein2 (AP2) orchestrates CXCR2-mediated cell migration.","date":"2014","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/24450359","citation_count":18,"is_preprint":false},{"pmid":"35203367","id":"PMC_35203367","title":"miR172 Regulates WUS during Somatic Embryogenesis in Arabidopsis via AP2.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35203367","citation_count":17,"is_preprint":false},{"pmid":"34494650","id":"PMC_34494650","title":"AAGAB is an assembly chaperone regulating AP1 and AP2 clathrin adaptors.","date":"2021","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/34494650","citation_count":17,"is_preprint":false},{"pmid":"37957699","id":"PMC_37957699","title":"ACSM5 inhibits ligamentum flavum hypertrophy by regulating lipid accumulation mediated by FABP4/PPAR signaling pathway.","date":"2023","source":"Biology direct","url":"https://pubmed.ncbi.nlm.nih.gov/37957699","citation_count":17,"is_preprint":false},{"pmid":"30536325","id":"PMC_30536325","title":"FABP4 accelerates glioblastoma cell growth and metastasis through Wnt10b signalling.","date":"2018","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30536325","citation_count":16,"is_preprint":false},{"pmid":"30521939","id":"PMC_30521939","title":"Extracellular FABP4 uptake by endothelial cells is dependent on cytokeratin 1 expression.","date":"2018","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/30521939","citation_count":16,"is_preprint":false},{"pmid":"39212041","id":"PMC_39212041","title":"FABP4 Enhances Lipidic and Fibrotic Cardiac Structural and Ca2+ Dynamic Changes.","date":"2024","source":"Circulation. Arrhythmia and electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/39212041","citation_count":15,"is_preprint":false},{"pmid":"36609276","id":"PMC_36609276","title":"Fatty acid-binding protein-4 (FABP4) and matrix metalloproteinase-9 (MMP9) as predictive values for nonalcoholic steatohepatitis (NASH).","date":"2023","source":"Lipids in health and disease","url":"https://pubmed.ncbi.nlm.nih.gov/36609276","citation_count":15,"is_preprint":false},{"pmid":"33666289","id":"PMC_33666289","title":"GoNe encoding a class VIIIb AP2/ERF is required for both extrafloral and floral nectary development in Gossypium.","date":"2021","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/33666289","citation_count":15,"is_preprint":false},{"pmid":"39073746","id":"PMC_39073746","title":"An AP2/ERF member LlERF012 confers thermotolerance via activation of HSF pathway in lily.","date":"2024","source":"Plant, cell & environment","url":"https://pubmed.ncbi.nlm.nih.gov/39073746","citation_count":15,"is_preprint":false},{"pmid":"33901630","id":"PMC_33901630","title":"PXR-mediated expression of FABP4 promotes valproate-induced lipid accumulation in HepG2 cells.","date":"2021","source":"Toxicology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33901630","citation_count":14,"is_preprint":false},{"pmid":"31767151","id":"PMC_31767151","title":"OsGL6, a conserved AP2 domain protein, promotes leaf trichome initiation in rice.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31767151","citation_count":14,"is_preprint":false},{"pmid":"34480404","id":"PMC_34480404","title":"BMP2K phosphorylates AP-2 and regulates clathrin-mediated endocytosis.","date":"2021","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/34480404","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48560,"output_tokens":4889,"usd":0.109507},"stage2":{"model":"claude-opus-4-6","input_tokens":8457,"output_tokens":3108,"usd":0.179978},"total_usd":0.289485,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"FABP4 triggers ubiquitination and subsequent proteasomal degradation of PPARγ, thereby attenuating adipogenesis. FABP4-null preadipocytes and macrophages exhibited increased PPARγ expression, and complementation of FABP4 in null macrophages reversed this increase.\",\n      \"method\": \"FABP4-null mouse preadipocytes/macrophages, complementation rescue experiments, ubiquitination assays, Western blot\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with defined molecular mechanism (PPARγ ubiquitination/degradation), complementation rescue, multiple orthogonal approaches\",\n      \"pmids\": [\"24319114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FABP4/aP2 regulates macrophage redox signaling and NLRP3 inflammasome activation via control of UCP2 expression. Ablation of FABP4 upregulates UCP2, reduces mitochondrial protein oxidation, attenuates the mitochondrial unfolded-protein response, and ablates IL-1β secretion in response to inflammasome activation.\",\n      \"method\": \"FABP4/aP2-knockout macrophages, FABP4 inhibitor treatment, UCP2 siRNA rescue, caspase-1 cleavage assay, IL-1β secretion assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined cellular phenotype, pharmacological inhibition, siRNA rescue, multiple orthogonal methods\",\n      \"pmids\": [\"27795298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FABP4 is secreted via an unconventional pathway involving enclosure within endosomes and secretory lysosomes, independent of the ER-Golgi pathway, GRASP proteins, autophagy, and multivesicular bodies. Chloroquine treatment in mice inhibits this secretion.\",\n      \"method\": \"Cell fractionation, live-cell imaging, pharmacological inhibitors of secretory pathways, chloroquine treatment of mice, Western blot of plasma FABP4\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple pathway inhibitors used orthogonally, in vivo validation, mechanistic pathway dissection\",\n      \"pmids\": [\"29212659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Hormonal FABP4 forms a functional hormone complex called Fabkin with adenosine kinase (ADK) and nucleoside diphosphate kinase (NDPK), regulating extracellular ATP and ADP levels. This complex acts on pancreatic beta cells and regulates an adipose-beta-cell endocrine axis. Antibody-mediated targeting of this complex improves beta-cell function and prevents diabetes.\",\n      \"method\": \"Co-immunoprecipitation, biochemical reconstitution, extracellular nucleotide measurements, antibody neutralization in mouse models of type 1 and type 2 diabetes, beta-cell functional assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — complex identification by co-IP, functional reconstitution, in vivo antibody targeting with defined physiological readout, published in Nature with multiple orthogonal methods\",\n      \"pmids\": [\"34880500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Endothelial cells are the major source of baseline circulating (hormonal) FABP4, contributing ~87% of basal plasma levels, whereas adipocytes are the main source of lipolysis-stimulated FABP4 increases. Endothelial FABP4 is required for lipolysis-driven insulin secretion.\",\n      \"method\": \"Cell-type-specific Fabp4 knockout mice (Adipo-KO, Endo-KO, Myeloid-KO, Total-KO), plasma FABP4 ELISA, lipolysis induction assays, insulin secretion measurements\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple conditional KO mouse lines with defined quantitative plasma measurements and functional insulin secretion readout\",\n      \"pmids\": [\"37279064\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PAK4 directly phosphorylates FABP4 at T126 and HSL at S565, impairing the FABP4-HSL interaction and thereby inhibiting lipolysis in adipose tissue. PKA-mediated degradation of PAK4 relieves this inhibition to allow lipolysis.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis (T126 on FABP4, S565 on HSL), co-immunoprecipitation, adipose tissue-specific PAK4 overexpression and knockout mice, lipolysis assays\",\n      \"journal\": \"Nature metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with mutagenesis identifying specific phosphorylation sites, in vivo genetic models, co-IP demonstrating functional consequence on FABP4-HSL interaction\",\n      \"pmids\": [\"38216738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Exogenous FABP4 interferes with adipocyte differentiation and induces p38/HSL-mediated lipolysis and p38/NF-κB-mediated inflammation in adipocytes in vitro and in vivo. These effects are reversed by FABP4 inhibitor I-9 or p38 MAPK inhibitor SB203580.\",\n      \"method\": \"3T3-L1 preadipocyte/adipocyte treatment with recombinant FABP4, p38 MAPK inhibitor, FABP4 inhibitor, in vivo mouse injections, Western blot for p38/HSL/NF-κB phosphorylation, RT-qPCR\",\n      \"journal\": \"Endocrine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological rescue experiments in vitro and in vivo, but single-lab study\",\n      \"pmids\": [\"31845180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"FABP4 overexpression in cardiomyocytes activates ERK phosphorylation and aggravates pressure overload-induced cardiac hypertrophy; this is inhibited by ERK inhibitor PD098059 or FABP4 inhibitor BMS309403.\",\n      \"method\": \"Heart-specific FABP4 transgenic mice (α-MHC promoter), transverse aortic constriction (TAC), Western blot for p-ERK, hypertrophic marker gene expression, pharmacological inhibition\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transgenic mouse model with TAC and pharmacological rescue, defined signaling pathway, single lab\",\n      \"pmids\": [\"27294862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FABP4 in tumor-associated macrophages directly binds ATPB and accelerates its ubiquitination, decreasing intracellular ATP levels, which deactivates the NF-κB/RelA-IL1α pathway and reprograms macrophages to an anti-inflammatory phenotype promoting neuroblastoma progression.\",\n      \"method\": \"Co-immunoprecipitation (FABP4-ATPB interaction), ubiquitination assays, NF-κB pathway analysis, IL1α blocking antibody rescue, in vitro and in vivo tumor growth assays\",\n      \"journal\": \"Clinical and translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP identifying direct binding partner, ubiquitination assay, pathway rescue with blocking antibody; single lab\",\n      \"pmids\": [\"33931964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Macrophage FABP4 is required for CXCL1 production, neutrophil recruitment, and bacterial clearance in Pseudomonas aeruginosa pneumonia. Bone marrow chimera experiments confirmed macrophages as the protective source of FABP4; recombinant CXCL1 rescued the FABP4-/- susceptibility phenotype.\",\n      \"method\": \"FABP4-/- mice, bone marrow chimeras, intratracheal P. aeruginosa infection, CXCL1 ELISA, recombinant CXCL1 rescue experiment\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — bone marrow chimeras establishing cell-type specificity, cytokine rescue experiment, mechanistic pathway defined; multiple orthogonal approaches\",\n      \"pmids\": [\"30462529\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"FABP4 deficiency in eosinophils impairs cell spreading, adhesion to ICAM-1 (via reduced β2-integrin expression), migration, F-actin polymerization, calcium flux, and ERK(1/2) phosphorylation in response to eotaxin-1, reducing eosinophil recruitment and allergic airway inflammation in vivo.\",\n      \"method\": \"FABP4-/- eosinophils, in vitro adhesion/migration assays, F-actin polymerization assay, calcium flux measurement, ERK phosphorylation (Western blot), cockroach antigen mouse model\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO cells with multiple orthogonal functional readouts in vitro and in vivo model; multiple mechanisms defined\",\n      \"pmids\": [\"29696987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"FABP4 activates the JAK2/STAT2 inflammatory pathway in macrophages via Rap1a-induced Tyr416 phosphorylation and membrane translocation of c-Src; SOCS1 provides a negative feedback loop inhibiting JAK2/STAT2 and Rap1a expression.\",\n      \"method\": \"Macrophage cell culture with Hcy stimulation, Western blot for JAK2/STAT2/c-Src phosphorylation, Rap1a knockdown/overexpression, ApoE-/- mouse atherosclerosis model\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined signaling pathway with genetic manipulation (Rap1a knockdown), in vivo model; single lab\",\n      \"pmids\": [\"34725437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Extracellular FABP4 is taken up by endothelial cells via cytokeratin 1 (CK1) acting as a membrane receptor; direct FABP4-CK1 binding was confirmed by surface plasmon resonance, and CK1 knockdown blocked eFABP4-mediated pro-inflammatory and pro-oxidative (NF-κB, NRF2) effects in endothelial cells.\",\n      \"method\": \"Surface plasmon resonance (direct protein-protein binding), siRNA knockdown of CK1 in HUVECs, Western blot for NF-κB/NRF2 nuclear translocation, cellular uptake assays\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular and cell biology of lipids\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — SPR for direct binding confirmation, siRNA knockdown with defined functional consequence; single lab\",\n      \"pmids\": [\"30521939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FABP4 in liver sinusoidal endothelial cells (LSECs) promotes CXCL10 expression via NF-κB/p65 signaling, which recruits CXCR3+ macrophages and drives M1 macrophage polarization during NAFLD progression. FABP4 inhibition suppresses this pathway.\",\n      \"method\": \"HFD mouse model, FABP4 inhibitor treatment, flow cytometry for macrophage subtypes, NF-κB inhibitor experiments, recombinant CXCL10 and CXCR3 inhibitor rescue, Western blot for nuclear p65\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular basis of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway defined with pharmacological and cytokine rescue experiments in vitro and in vivo; single lab\",\n      \"pmids\": [\"37487374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Tamoxifen inhibits macrophage FABP4 expression through combined effects on the glucocorticoid receptor (GR) activating a negative GRE (nGRE) and inhibiting the PPARγ regulatory element (PPRE) in the Fabp4 promoter, reducing foam cell formation and atherosclerosis.\",\n      \"method\": \"Promoter-reporter assays, EMSA, ChIP, siRNA knockdown of FABP4, primary macrophages from wild-type/ApoE-/- mice, in vivo tamoxifen administration\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — EMSA and ChIP identifying specific cis-regulatory elements, promoter-reporter assays, in vivo validation; multiple orthogonal methods\",\n      \"pmids\": [\"23805908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Bisphenol A increases FABP4/aP2 expression in 3T3-L1 cells through enhanced transcriptional activity of C/EBPδ and glucocorticoid receptor (GR) at the FABP4 promoter, independently of PPARγ or C/EBPα elevation.\",\n      \"method\": \"3T3-L1 differentiation assay, RT-qPCR, Western blot, promoter-reporter assay, nuclear receptor pathway analysis\",\n      \"journal\": \"Adipocyte\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — promoter activity assay with pharmacological dissection; single lab, limited mechanistic depth\",\n      \"pmids\": [\"25068083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FABP4 secreted by M1-polarized macrophages promotes synovitis and angiogenesis in rheumatoid arthritis. mTORC1 (regulated by TSC1 and Rheb1 in myeloid cells) controls FABP4 expression in macrophages; inhibiting FABP4 with BMS309403 or reducing its expression via mTORC1 inhibition alleviates RA.\",\n      \"method\": \"Myeloid-specific TSC1-KO and Rheb1-KO mice, BMS309403 pharmacological inhibition, in vitro synoviocyte/angiogenesis assays, in vivo mouse RA models\",\n      \"journal\": \"Bone research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific genetic models placing FABP4 downstream of mTORC1 signaling; single lab\",\n      \"pmids\": [\"35729106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"FABP4 exerts a negative feedback loop on FAT/CD36 signaling in adipocytes: fatty acid-mediated FAT/CD36-PPARγ transcriptional activation induces FABP4 accumulation, which in turn reduces FAT/CD36 activity and controls adipocyte size and number (fat mass expandability).\",\n      \"method\": \"Human adipose stem cells, 3T3-L1 and 3T3-MBX cell lines, real-time proliferation/differentiation/lipolysis/lipid uptake assays, FABP4 overexpression/knockdown, FAT/CD36 signaling pathway analysis\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined feedback loop with gain/loss-of-function approaches; single lab\",\n      \"pmids\": [\"36674544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PXR transcriptionally upregulates FABP4 expression in HepG2 cells in response to valproate, and FABP4 promotes lipid/triglyceride accumulation; knockdown of PXR reduces FABP4 induction and lipid accumulation, while FABP4 overexpression enhances VPA-induced steatosis.\",\n      \"method\": \"PXR siRNA knockdown, PXR overexpression, FABP4 overexpression in HepG2 cells, triglyceride measurement, lipid staining\",\n      \"journal\": \"Toxicology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function for both PXR and FABP4; single lab\",\n      \"pmids\": [\"33901630\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FABP4 is an intracellular lipid chaperone and secreted adipokine/hormone that: (1) regulates adipogenesis and PPARγ levels by promoting PPARγ ubiquitination and proteasomal degradation; (2) is secreted unconventionally via endosomes and secretory lysosomes (primarily from endothelial cells at baseline and from adipocytes during lipolysis); (3) forms a hormone complex (Fabkin) with ADK and NDPK to regulate extracellular nucleotide levels and beta-cell function; (4) is directly phosphorylated by PAK4 at T126, impairing its interaction with HSL to inhibit lipolysis; (5) controls macrophage redox signaling and NLRP3 inflammasome activation via UCP2; and (6) is taken up by endothelial cells via cytokeratin 1 to activate inflammatory signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FABP4 is an intracellular lipid chaperone and unconventionally secreted adipokine that integrates lipid metabolism, inflammatory signaling, and systemic endocrine communication across adipocytes, macrophages, and endothelial cells. Intracellularly, FABP4 promotes PPARγ ubiquitination and proteasomal degradation to restrain adipogenesis [PMID:24319114], participates in a negative feedback loop with FAT/CD36 to control fat mass expandability [PMID:36674544], and its interaction with hormone-sensitive lipase (HSL) is regulated by PAK4-mediated phosphorylation at T126 to control lipolysis [PMID:38216738]. Secreted FABP4 forms the Fabkin hormone complex with adenosine kinase and nucleoside diphosphate kinase to regulate extracellular ATP/ADP levels and pancreatic β-cell insulin secretion, with endothelial cells contributing ~87% of basal circulating FABP4 via an unconventional endosome/secretory lysosome pathway [PMID:34880500, PMID:37279064, PMID:29212659]. In macrophages, FABP4 controls NLRP3 inflammasome activation through UCP2-dependent mitochondrial redox regulation [PMID:27795298], drives CXCL1-dependent neutrophil recruitment during bacterial infection [PMID:30462529], and in eosinophils supports integrin-mediated adhesion, migration, and cytoskeletal dynamics [PMID:29696987].\",\n  \"teleology\": [\n    {\n      \"year\": 2013,\n      \"claim\": \"Establishing how FABP4 controls adipogenesis at the molecular level: FABP4 was shown to promote PPARγ ubiquitination and proteasomal degradation, explaining how a fatty acid-binding protein feeds back to limit the master adipogenic transcription factor.\",\n      \"evidence\": \"FABP4-null preadipocytes/macrophages with elevated PPARγ, complementation rescue, ubiquitination assays\",\n      \"pmids\": [\"24319114\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ubiquitin ligase mediating FABP4-dependent PPARγ ubiquitination not identified\", \"structural basis for FABP4-PPARγ interaction unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Defining transcriptional regulation of FABP4 itself: the FABP4 promoter was shown to integrate signals from both GR (via a negative GRE) and PPARγ (via PPRE), explaining how tamoxifen suppresses macrophage FABP4 and reduces foam cell formation.\",\n      \"evidence\": \"EMSA, ChIP, promoter-reporter assays, in vivo tamoxifen treatment in ApoE−/− mice\",\n      \"pmids\": [\"23805908\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other nuclear receptors contribute to FABP4 regulation in non-macrophage lineages not tested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealing how FABP4 links lipid sensing to innate immune activation: FABP4 was found to control the NLRP3 inflammasome via UCP2-dependent mitochondrial redox regulation in macrophages, connecting lipid metabolism to IL-1β production.\",\n      \"evidence\": \"FABP4 KO and inhibitor-treated macrophages, UCP2 siRNA rescue, caspase-1 cleavage and IL-1β secretion assays\",\n      \"pmids\": [\"27795298\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which FABP4 regulates UCP2 expression (transcriptional vs. post-transcriptional) not resolved\", \"whether specific lipid cargo of FABP4 is required for inflammasome regulation unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identifying the unconventional secretory route of FABP4: secretion occurs via endosomes and secretory lysosomes, independent of ER-Golgi, GRASP proteins, autophagy, or multivesicular bodies, explaining how a cytosolic protein reaches the circulation.\",\n      \"evidence\": \"Cell fractionation, live-cell imaging, pharmacological pathway inhibitors, in vivo chloroquine treatment reducing plasma FABP4\",\n      \"pmids\": [\"29212659\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal or motif on FABP4 that targets it to endosomes not identified\", \"regulation of secretory lysosome exocytosis of FABP4 not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Establishing cell-autonomous roles in immune cell function beyond macrophages: FABP4 deficiency in eosinophils impaired integrin-mediated adhesion, F-actin polymerization, calcium flux, and migration, revealing a general role in leukocyte cytoskeletal dynamics.\",\n      \"evidence\": \"FABP4-KO eosinophils, adhesion/migration assays, calcium flux, ERK phosphorylation, allergic airway inflammation model\",\n      \"pmids\": [\"29696987\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target linking FABP4 to β2-integrin surface expression not identified\", \"whether lipid-binding pocket occupancy is required for cytoskeletal effects unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identifying a membrane receptor for extracellular FABP4: cytokeratin 1 (CK1) on endothelial cells was shown by surface plasmon resonance to directly bind FABP4, and CK1 knockdown blocked FABP4-mediated NF-κB and NRF2 activation, establishing a receptor-mediated uptake mechanism.\",\n      \"evidence\": \"SPR direct binding, CK1 siRNA in HUVECs, NF-κB/NRF2 nuclear translocation assays\",\n      \"pmids\": [\"30521939\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"CK1 as a FABP4 receptor not independently replicated\", \"whether CK1 mediates FABP4 signaling in non-endothelial cells untested\", \"downstream signaling cascade between CK1 engagement and NF-κB activation not mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating a macrophage-specific protective role in innate immunity: FABP4 in macrophages was required for CXCL1 production and neutrophil recruitment during bacterial pneumonia, with bone marrow chimeras establishing macrophages as the protective cell source.\",\n      \"evidence\": \"FABP4−/− mice, bone marrow chimeras, Pseudomonas aeruginosa pneumonia model, recombinant CXCL1 rescue\",\n      \"pmids\": [\"30462529\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism connecting FABP4 to CXCL1 transcription in macrophages not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Discovering the Fabkin hormone complex: FABP4 was found to form a functional extracellular complex with ADK and NDPK that regulates ATP/ADP levels and acts on pancreatic β-cells, transforming understanding of FABP4 from intracellular chaperone to systemic hormone.\",\n      \"evidence\": \"Co-immunoprecipitation, biochemical reconstitution, extracellular nucleotide measurements, anti-Fabkin antibody in mouse diabetes models\",\n      \"pmids\": [\"34880500\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structural basis of the Fabkin complex not resolved\", \"how FABP4 and its partners are co-secreted or assemble extracellularly not determined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Resolving the cellular source of circulating FABP4: conditional KO mice revealed endothelial cells as the dominant source of basal circulating FABP4 (~87%) while adipocytes contribute the lipolysis-stimulated increase, establishing tissue-specific endocrine roles.\",\n      \"evidence\": \"Cell-type-specific Fabp4 KO mice (adipocyte, endothelial, myeloid, total), plasma ELISA, lipolysis-stimulated insulin secretion assays\",\n      \"pmids\": [\"37279064\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endothelial and adipocyte FABP4 differ in Fabkin complex formation not tested\", \"signals regulating basal endothelial FABP4 secretion not identified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identifying a direct kinase controlling FABP4-HSL interaction: PAK4 phosphorylates FABP4 at T126 and HSL at S565, disrupting their interaction and inhibiting lipolysis; PKA-mediated PAK4 degradation relieves this brake, integrating FABP4 into the catecholamine-lipolysis signaling cascade.\",\n      \"evidence\": \"In vitro kinase assay, T126/S565 mutagenesis, co-IP, adipose-specific PAK4 overexpression/KO mice, lipolysis assays\",\n      \"pmids\": [\"38216738\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether T126 phosphorylation also affects FABP4 secretion or Fabkin complex formation not examined\", \"crystal structure of phospho-T126 FABP4 not available\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: how the Fabkin complex assembles and signals at target cells, what lipid cargoes are required for distinct FABP4 functions, and how FABP4 is sorted into secretory lysosomes for unconventional secretion.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Structural basis and stoichiometry of Fabkin complex\", \"lipid-cargo dependence of individual FABP4 functions\", \"sorting signal for FABP4 entry into secretory lysosomes\", \"whether CK1-mediated uptake applies to cell types beyond endothelium\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 5, 17]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 3, 17]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 1, 5]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [2, 3, 4, 12]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 5, 17, 18]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 9, 10]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 5, 7, 11]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 8]}\n    ],\n    \"complexes\": [\n      \"Fabkin (FABP4-ADK-NDPK)\"\n    ],\n    \"partners\": [\n      \"HSL\",\n      \"PAK4\",\n      \"ADK\",\n      \"NDPK\",\n      \"PPARγ\",\n      \"CK1 (KRT1)\",\n      \"ATPB (ATP5B)\",\n      \"UCP2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}